abstract |
The present invention provides a compound represented by formula I, its tautomer, stereoisomer, hydrate, solvate, pharmaceutically acceptable salt or prodrug; the compound has an effective antagonistic effect on EP4 , has a good affinity with the EP4 receptor and can act as an EP4 antagonist. |